2014
DOI: 10.1111/jnc.12708
|View full text |Cite
|
Sign up to set email alerts
|

2‐Methoxyestradiol confers neuroprotection and inhibits a maladaptive HIF‐1α response after traumatic brain injury in mice

Abstract: HIF-1a is pivotal for cellular homeostasis in response to cerebral ischemia. Pharmacological inhibition of HIF-1a may reduce secondary brain damage by targeting post-translational mechanisms associated with its proteasomal degradation and nuclear translocation. This study examined the neuroprotective effects of 2-methoxyestradiol (2ME2), the involved HIF-1a-dependent response, and alternative splicing in exon 14 of HIF-1a (HIF-1aΔEx14) after traumatic brain injury (TBI) in mice. Intraperitoneal 2ME2 administra… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

2
46
0

Year Published

2014
2014
2017
2017

Publication Types

Select...
7
1
1

Relationship

2
7

Authors

Journals

citations
Cited by 59 publications
(48 citation statements)
references
References 88 publications
(192 reference statements)
2
46
0
Order By: Relevance
“…2-ME is protective against experimental autoimmune encephalomyelitis (16), neurodamage following traumatic brain injury (33), and brain infarction following middle cerebral artery occlusion-induced focal ischemia (8). These findings, along with our results, suggest that endogenous 2-ME may play an important role in mediating the protective effects of estradiol.…”
Section: Discussionsupporting
confidence: 71%
See 1 more Smart Citation
“…2-ME is protective against experimental autoimmune encephalomyelitis (16), neurodamage following traumatic brain injury (33), and brain infarction following middle cerebral artery occlusion-induced focal ischemia (8). These findings, along with our results, suggest that endogenous 2-ME may play an important role in mediating the protective effects of estradiol.…”
Section: Discussionsupporting
confidence: 71%
“…Indeed, 2-ME is a potential therapeutic agent that is protective against cardiovascular disease and multiple proliferative and immune disorders such as cancer and rheumatoid arthritis (12,28). Importantly, 2-ME inhibits experimental autoimmune encephalomyelitis via suppression of lymphocyte activation (16), induces neuroprotection following traumatic brain injury by inhibiting maladaptive HIF-1␣ responses (33), and reduces brain infarct size in a middle cerebral artery occlusion-induced focal ischemia rat model (8). Decreased levels of 2-ME are observed in patients with Parkinson's disease (18), and significant increases in 2-ME levels during the last months of pregnancy seem to correlate temporally with remission of clinical symptoms in some pregnant multiple sclerosis and rheumatoid arthritis patients (27,28).…”
mentioning
confidence: 99%
“…There are inconsistent data concerning neuroprotective and neurotoxic effects of 2-ME. Neuroprotective effects of 2-ME were reported in several mice and rat models [22,64]. 2-ME was found to suppress HIF1α and VEGF and reduce apoptosis, brain edema, and neurologic scores based on the scoring system reported by Garcia [22].…”
Section: Discussionmentioning
confidence: 95%
“…The adult rat brain showed a 52% decrease in cortical cerebral blood flow (CBF) within 15 minutes of FPI, which persisted for 4 hours and then returned to the original CBF level at 24 hours post-injury [32]. Compared to the contusion volume of the primary lesion, which was determined 15 minutes after TBI, the contusion volume in the mouse controlled cortical impact (CCI) model increased approximately two-fold over 24 hours [33]. In a rat model of FPI, the contusion volume increased approximately six-fold over 4 days compared to that in the primary lesion (as shown in the present study).…”
Section: Discussionmentioning
confidence: 99%